YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. is considering a merger of its off-patent drug business with generic drugmaker Mylan, people familiar with the matter told The Wall Street Journal.
Under the proposal, Mylan shareholders would own more than 40% of the new entity and Pfizer shareholders would own the remainder.
Such a deal would create a global company that sells lower-priced pharmaceuticals.
Read more from The Wall Street Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects